Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 22.44% ...
On Friday, Prime Medicine Inc (PRME) stock saw a decline, ending the day at $3.46 which represents a decrease of $-0.10 or -2.81% from the prior close of $3.56. The stock opened at $3.62 and touched a ...